scispace - formally typeset
R

Radka Obermannova

Researcher at Masaryk University

Publications -  59
Citations -  2505

Radka Obermannova is an academic researcher from Masaryk University. The author has contributed to research in topics: Cancer & Ramucirumab. The author has an hindex of 13, co-authored 44 publications receiving 1789 citations. Previous affiliations of Radka Obermannova include European Organisation for Research and Treatment of Cancer.

Papers
More filters
Journal ArticleDOI

Management of Metastatic Gastric Cancer

TL;DR: The indication and clinical data of medical treatment of advanced gastric cancer is outlined and aspects of quality of life are highlighted.
Journal ArticleDOI

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.

Tiuri E. Kroese, +119 more
TL;DR: A broad consensus on definitions of oligometastatic oesophagogastric cancer was found among multidisciplinary tumour boards (MDTs) in Europe as discussed by the authors , however, high practice variability in treatment strategies exists.
Journal ArticleDOI

Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.

TL;DR: In this paper , the role of the modified Glasgow prognostic score (mGPS), consisting of inflammation parameters plasma C-reactive protein (CRP) and albumin, to predicting sarcopenia and adipose tissue-related body composition (BC) parameters at baseline and their changes during treatment was analyzed.
Journal ArticleDOI

Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence

TL;DR: The results of this large single institutional retrospective study of consecutive patients showed the significant role of adding platinum salts in older patients with high-proliferative early responded tumors and persisted lymph nodes involvement regardless of BRCA1/2 status.